Results 111 to 120 of about 5,304 (170)

Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study. [PDF]

open access: yesBlood Adv
Eyre TA   +31 more
europepmc   +1 more source

Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia. [PDF]

open access: yesHemasphere
Chu CC   +11 more
europepmc   +1 more source

Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors. [PDF]

open access: yesCancer Med
Schulze FJ   +8 more
europepmc   +1 more source

Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL. [PDF]

open access: yesOncol Ther
Ermann DA   +12 more
europepmc   +1 more source

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience. [PDF]

open access: yesBr J Haematol
Duminuco A   +21 more
europepmc   +1 more source

Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up. [PDF]

open access: yesAdv Ther
Shadman M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy